{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:45:37Z","timestamp":1792165537767,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T00:00:00Z","timestamp":1329782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00109-012-0881-4","type":"journal-article","created":{"date-parts":[[2012,2,20]],"date-time":"2012-02-20T02:56:21Z","timestamp":1329706581000},"page":"911-923","source":"Crossref","is-referenced-by-count":127,"title":["A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells"],"prefix":"10.1007","volume":"90","author":[{"given":"Fan","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Lian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Wei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C. K.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zhong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,21]]},"reference":[{"key":"881_CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370:685\u2013697","journal-title":"Lancet"},{"key":"881_CR2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","volume":"91","author":"N Xita","year":"2006","unstructured":"Xita N, Tsatsoulis A (2006) Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91:1660\u20131666","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","volume":"8","author":"DA Dumesic","year":"2007","unstructured":"Dumesic DA, Abbott DH, Padmanabhan V (2007) Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 8:127\u2013141","journal-title":"Rev Endocr Metab Disord"},{"key":"881_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 7:219\u2013231","journal-title":"Nat Rev Endocrinol"},{"key":"881_CR5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1051\/medsci\/2005215507","volume":"21","author":"P Froment","year":"2005","unstructured":"Froment P, Gizard F, Staels B, Dupont J, Monget P (2005) A role of PPARgamma in reproduction? Med Sci (Paris) 21:507\u2013511","journal-title":"Med Sci (Paris)"},{"key":"881_CR6","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1210\/jc.82.7.2108","volume":"82","author":"DA Ehrmann","year":"1997","unstructured":"Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS (1997) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108\u20132116","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1210\/jc.86.4.1626","volume":"86","author":"R Azziz","year":"2001","unstructured":"Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN (2001) Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab 86:1626\u20131632","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR8","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2003-031737","volume":"89","author":"N Brettenthaler","year":"2004","unstructured":"Brettenthaler N, De Geyter C, Huber PR, Keller U (2004) Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3835\u20133840","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","volume":"90","author":"V Sepilian","year":"2005","unstructured":"Sepilian V, Nagamani M (2005) Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab 90:60\u201365","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR10","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1074\/jbc.M507784200","volume":"281","author":"Z Gao","year":"2006","unstructured":"Gao Z, He Q, Peng B, Chiao PJ, Ye J (2006) Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. J Biol Chem 281:4540\u20134547","journal-title":"J Biol Chem"},{"key":"881_CR11","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1128\/MCB.21.18.6091-6101.2001","volume":"21","author":"MG Guenther","year":"2001","unstructured":"Guenther MG, Barak O, Lazar MA (2001) The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21:6091\u20136101","journal-title":"Mol Cell Biol"},{"key":"881_CR12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)00064-7","volume":"102","author":"K Jepsen","year":"2000","unstructured":"Jepsen K, Hermanson O, Onami TM, Gleiberman AS, Lunyak V, McEvilly RJ, Kurokawa R, Kumar V, Liu F, Seto E et al (2000) Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102:753\u2013763","journal-title":"Cell"},{"key":"881_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","volume":"30","author":"S Bhaskara","year":"2008","unstructured":"Bhaskara S, Chyla BJ, Amann JM, Knutson SK, Cortez D, Sun ZW, Hiebert SW (2008) Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell 30:61\u201372","journal-title":"Mol Cell"},{"key":"881_CR14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nature07541","volume":"456","author":"T Alenghat","year":"2008","unstructured":"Alenghat T, Meyers K, Mullican SE, Leitner K, Adeniji-Adele A, Avila J, Bucan M, Ahima RS, Kaestner KH, Lazar MA (2008) Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456:997\u20131000","journal-title":"Nature"},{"key":"881_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","journal-title":"Hum Reprod"},{"key":"881_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0301-2115(99)00260-2","volume":"91","author":"N Nikolettos","year":"2000","unstructured":"Nikolettos N, Kupker W, Al-Hasani S, Demirel LC, Schopper B, Sturm R, Diedrich K (2000) ICSI outcome in patients of 40\u00a0years age and over: a retrospective analysis. Eur J Obstet Gynecol Reprod Biol 91:177\u2013182","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"881_CR17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/humrep\/deq078","volume":"25","author":"F Qu","year":"2010","unstructured":"Qu F, Wang FF, Lu XE, Dong MY, Sheng JZ, Lv PP, Ding GL, Shi BW, Zhang D, Huang HF (2010) Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway. Hum Reprod 25:1441\u20131450","journal-title":"Hum Reprod"},{"key":"881_CR18","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1210\/jc.2006-1935","volume":"92","author":"D Seto-Young","year":"2007","unstructured":"Seto-Young D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J, Holcomb K, Rosenwaks Z, Poretsky L (2007) Interactions among peroxisome proliferator activated receptor-gamma, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells. J Clin Endocrinol Metab 92:2232\u20132239","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR19","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1210\/en.2008-0459","volume":"149","author":"K Sayasith","year":"2008","unstructured":"Sayasith K, Bouchard N, Dore M, Sirois J (2008) Regulation of bovine tumor necrosis factor alpha induced protein 6 in ovarian follicles during the ovulatory process and promoter activation in granulosa cells. Endocrinology 149:6213\u20136225","journal-title":"Endocrinology"},{"key":"881_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1095\/biolreprod.103.023549","volume":"71","author":"R Roberts","year":"2004","unstructured":"Roberts R, Stark J, Iatropoulou A, Becker DL, Franks S, Hardy K (2004) Energy substrate metabolism of mouse cumulus-oocyte complexes: response to follicle-stimulating hormone is mediated by the phosphatidylinositol 3-kinase pathway and is associated with oocyte maturation. Bio Reprod 71:199\u2013209","journal-title":"Bio Reprod"},{"issue":"Suppl 2","key":"881_CR21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.fertnstert.2005.06.017","volume":"84","author":"N Tamura","year":"2005","unstructured":"Tamura N, Kurabayashi T, Nagata H, Matsushita H, Yahata T, Tanaka K (2005) Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome. Fertil Steril 84(Suppl 2):1277\u20131284","journal-title":"Fertil Steril"},{"key":"881_CR22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.steroids.2006.05.005","volume":"71","author":"SA Doi","year":"2006","unstructured":"Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KA (2006) Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids 71:751\u2013759","journal-title":"Steroids"},{"key":"881_CR23","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1093\/nar\/24.24.5064","volume":"24","author":"A Olek","year":"1996","unstructured":"Olek A, Oswald J, Walter J (1996) A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 24:5064\u20135066","journal-title":"Nucleic Acids Res"},{"key":"881_CR24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D (2006) Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 91:941\u2013945","journal-title":"J Clin Endocrinol Metab"},{"key":"881_CR25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/molehr\/7.4.325","volume":"7","author":"E Shalev","year":"2001","unstructured":"Shalev E, Goldman S, Ben-Shlomo I (2001) The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women. Mol Hum Reprod 7:325\u2013331","journal-title":"Mol Hum Reprod"},{"key":"881_CR26","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/sj.onc.1210612","volume":"26","author":"P Karagianni","year":"2007","unstructured":"Karagianni P, Wong J (2007) HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26:5439\u20135449","journal-title":"Oncogene"},{"key":"881_CR27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1525-1373.2000.22342.x","volume":"223","author":"F Sun","year":"2000","unstructured":"Sun F, Yu J (2000) The effect of a special herbal tea on obesity and anovulation in androgen-sterilized rats. Proc Soc Exp Biol Med 223:295\u2013301","journal-title":"Proc Soc Exp Biol Med"},{"key":"881_CR28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1450619","volume":"145","author":"HF Escobar-Morreale","year":"2001","unstructured":"Escobar-Morreale HF, Asuncion M, Calvo RM, Sancho J, San Millan JL (2001) Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 145:619\u2013624","journal-title":"Eur J Endocrinol"},{"key":"881_CR29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(16)58146-1","volume":"65","author":"P Koskinen","year":"1996","unstructured":"Koskinen P, Penttila TA, Anttila L, Erkkola R, Irjala K (1996) Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome. Fertil Steril 65:517\u2013522","journal-title":"Fertil Steril"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-012-0881-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-012-0881-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-012-0881-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:29:06Z","timestamp":1558571346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-012-0881-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,21]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1007\/s00109-012-0881-4","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,21]]}}}